Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Medical therapy for pediatric pulmonary arterial hypertension.

Literature DB >> 20656296

Medical therapy for pediatric pulmonary arterial hypertension.

Cecile Tissot¹, David Dunbar Ivy, Maurice Beghetti.

Abstract

Entities: Chemical Disease Gene Species

Mesh：

Substances：

Year: 2010 PMID： 20656296 PMCID： PMC3127257 DOI： 10.1016/j.jpeds.2010.06.010

Source DB: PubMed Journal: J Pediatr ISSN： 0022-3476 Impact factor: 4.406

× No keyword cloud information.

48 in total

Review 1. Updated clinical classification of pulmonary hypertension.

Authors: Gérald Simonneau; Ivan M Robbins; Maurice Beghetti; Richard N Channick; Marion Delcroix; Christopher P Denton; C Gregory Elliott; Sean P Gaine; Mark T Gladwin; Zhi-Cheng Jing; Michael J Krowka; David Langleben; Norifumi Nakanishi; Rogério Souza
Journal: J Am Coll Cardiol Date: 2009-06-30 Impact factor: 24.094

2. Sildenafil citrate therapy for pulmonary arterial hypertension.

Authors: Nazzareno Galiè; Hossein A Ghofrani; Adam Torbicki; Robyn J Barst; Lewis J Rubin; David Badesch; Thomas Fleming; Tamiza Parpia; Gary Burgess; Angelo Branzi; Friedrich Grimminger; Marcin Kurzyna; Gérald Simonneau
Journal: N Engl J Med Date: 2005-11-17 Impact factor: 91.245

3. Safety and efficacy of inhaled treprostinil as add-on therapy to bosentan in pulmonary arterial hypertension.

Authors: Richard N Channick; Horst Olschewski; Werner Seeger; Ted Staub; Robert Voswinckel; Lewis J Rubin
Journal: J Am Coll Cardiol Date: 2006-09-14 Impact factor: 24.094

4. Inhaled nitric oxide to test the vasodilator capacity of the pulmonary vascular bed in children with long-standing pulmonary hypertension and congenital heart disease.

Authors: M Berner; M Beghetti; I Spahr-Schopfer; I Oberhansli; B Friedli
Journal: Am J Cardiol Date: 1996-03-01 Impact factor: 2.778

5. Pulmonary arterial hypertension in children: Diagnostic work-up and challenges.

Authors: E B Rosenzweig; J A Feinstein; T Humpl; D D Ivy
Journal: Prog Pediatr Cardiol Date: 2009-12

6. Intravenous sildenafil in the treatment of neonates with persistent pulmonary hypertension.

Authors: Robin H Steinhorn; John P Kinsella; Christine Pierce; Ghazwan Butrous; Maria Dilleen; Michael Oakes; David L Wessel
Journal: J Pediatr Date: 2009-12 Impact factor: 4.406

7. Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT).

Authors: Nazzareno Galiè; Marius M Hoeper; Marc Humbert; Adam Torbicki; Jean-Luc Vachiery; Joan Albert Barbera; Maurice Beghetti; Paul Corris; Sean Gaine; J Simon Gibbs; Miguel Angel Gomez-Sanchez; Guillaume Jondeau; Walter Klepetko; Christian Opitz; Andrew Peacock; Lewis Rubin; Michael Zellweger; Gerald Simonneau
Journal: Eur Heart J Date: 2009-08-27 Impact factor: 29.983

8. Safety experience with bosentan in 146 children 2-11 years old with pulmonary arterial hypertension: results from the European Postmarketing Surveillance program.

Authors: Maurice Beghetti; Marius M Hoeper; David G Kiely; Joern Carlsen; Barbara Schwierin; Eleanor S Segal; Marc Humbert
Journal: Pediatr Res Date: 2008-08 Impact factor: 3.756

9. Addition of sildenafil to long-term intravenous epoprostenol therapy in patients with pulmonary arterial hypertension: a randomized trial.

Authors: Gérald Simonneau; Lewis J Rubin; Nazzareno Galiè; Robyn J Barst; Thomas R Fleming; Adaani E Frost; Peter J Engel; Mordechai R Kramer; Gary Burgess; Lorraine Collings; Nandini Cossons; Olivier Sitbon; David B Badesch
Journal: Ann Intern Med Date: 2008-10-21 Impact factor: 25.391

10. Primary pulmonary hypertension in children: clinical characterization and survival.

Authors: J Sandoval; O Bauerle; A Gomez; A Palomar; M L Martínez Guerra; M E Furuya
Journal: J Am Coll Cardiol Date: 1995-02 Impact factor: 24.094

13 in total

Review 1. Advances in pediatric pulmonary arterial hypertension.

Authors: Dunbar Ivy
Journal: Curr Opin Cardiol Date: 2012-03 Impact factor: 2.161

2. Trends in pediatric pulmonary hypertension-related hospitalizations in the United States from 2000-2009.

Authors: David B Frank; Matthew A Crystal; David L S Morales; Ken Gerald; Brian D Hanna; George B Mallory; Joseph W Rossano
Journal: Pulm Circ Date: 2015-06 Impact factor: 3.017

Review 3. Drug treatment of pulmonary hypertension in children.

Authors: Erika E Vorhies; David Dunbar Ivy
Journal: Paediatr Drugs Date: 2014-02 Impact factor: 3.022

Review 4. Challenges in the diagnosis and treatment of juvenile systemic sclerosis.

Authors: C Egla Rabinovich
Journal: Nat Rev Rheumatol Date: 2011-10-11 Impact factor: 20.543

Review 5. Recent progress in understanding pediatric pulmonary hypertension.

Authors: Steven H Abman; D Dunbar Ivy
Journal: Curr Opin Pediatr Date: 2011-06 Impact factor: 2.856

Review 6. Pharmacotherapy for pulmonary hypertension.

Authors: Robin H Steinhorn
Journal: Pediatr Clin North Am Date: 2012-08-26 Impact factor: 3.278

7. Use of inhaled iloprost for the management of postoperative pulmonary hypertension in congenital heart surgery patients: review of a transition protocol.

Authors: Erika E Vorhies; Regine L Caruthers; Howard Rosenberg; Sunkyung Yu; Robert J Gajarski
Journal: Pediatr Cardiol Date: 2014-05-29 Impact factor: 1.655